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Abstract  
CD8+ cytotoxic T-lymphocytes (CTLs) eliminate virally infected cells through directed 
secretion of specialized lytic granules. Because a single CTL can kill multiple targets, 
degranulation must be tightly regulated. However, how CTLs regulate the termination of granule 
secretion remains unclear. Previous work demonstrated that centralized actin depletion at the 
immune synapse precedes degranulation. Using a combination of live confocal, TIRF, and super-
resolution microscopy, we now show that after granule fusion, actin recovers at the synapse and 
no further secretion is observed. Depolymerization of actin led to resumed granule secretion, 
suggesting recovered actin acts as a barrier preventing sustained degranulation. Furthermore, 
RAB27a-deficient CTLs, which do not secrete cytotoxic granules, failed to recover actin at the 
synapse, suggesting that RAB27a-mediated granule secretion is required for actin recovery. 
Finally, we show that both actin clearance and recovery correlated with synaptic PIP2, and that 
alterations in PIP2 at the immunological synapse regulate cortical actin in CTLs, providing a 
potential mechanism through which CTLs control cortical actin density. Our work provides 
insight into actin-related mechanisms regulating CTL secretion that may facilitate serial killing 
during immune responses.   
  3 
Introduction 
 
Cytotoxic CD8+ T lymphocytes (CTLs) are critical for both the elimination of cells 
infected with intracellular pathogens and for the surveillance of tumors. CTLs carry out their 
cytolytic functions through the directed secretion of lytic granules, specialized lysosomes that 
contain perforin and granzymes that induce death of target cells. Because a single CTL is capable 
of killing multiple target cells during an immune response (1, 2), they are thought to act as 
“serial killers” (3). As such, CTLs need to tightly regulate secretion, both in order to kill only 
appropriate target cells on contact, and to facilitate their ability to carry out serial responses. Data 
suggest that each CTL releases only a small number of granules per productive killing outcome 
(4-6). However, how CTLs regulate both the initiation and the termination of granule secretion 
during an individual CTL:target interaction is still not completely understood. 
A dense meshwork of cortical actin abuts the plasma membrane and envelops the cytosol 
of animal cells. Acute reduction of cortical actin density has been shown to regulate access of 
secretory granules to the plasma membrane and facilitate secretion in a number of cell types (7, 
8). Notably, CTL recognition of a target is accompanied by rapid changes in cortical actin 
density resulting in a dramatic reduction of actin density at the interface between the CTL and its 
target (9, 10). Moreover, this reduction in cortical actin in CTLs is spatially and temporally 
correlated with the secretion of lytic granules (10). Conversely, elevated cortical actin density at 
the immunological synapse has been correlated with defective lytic granule secretion (11, 12). 
Nonetheless, the extent to which modulation of actin contributes to the regulation of secretion 
during later stages of T cell:target interactions and the termination of secretion is largely 
unknown.  
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To further explore the role of the cortical actin cytoskeleton in regulating both the 
initiation and the termination of secretion of cytolytic granules in CTLs, we used 3-dimensional, 
multicolor, live cell microscopy and total internal reflection fluorescence (TIRF) microscopy to 
directly examine the dynamics of cortical actin before, during, and after lytic granule secretion. 
Our results suggest that cortical actin density is tightly regulated to either permit or restrict 
access of lytic granules to the plasma membrane during target engagement. Furthermore, our 
data reveal a correlation between RAB27a-dependent secretion, the recovery of actin, and 
phosphatidylinositol 4,5-bisphosphate (PIP2) at the synapse, suggesting that the distribution of 
PIP2 in the membrane represents a potential mechanism through which CTLs regulate the density 
of cortical actin during cytolysis. Thus, by regulating the actin cytoskeleton, CTLs control both 
the initiation and termination of secretion, providing a potential mechanism to make them 
effective serial killers during an immune response. 
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Results  
Cortical actin recovers at the synapse following lytic granule secretion 
To evaluate cortical actin dynamics in the context of CTL cytolytic activity, we first 
employed live cell spinning disk confocal microscopy to follow actin during the entire course of 
CTL interactions with their targets. CTLs were derived from OT-I T cell receptor transgenic 
mice that recognize a peptide from Ovalbumin and were used in conjunction with peptide-pulsed 
targets expressing the Ca2+ indicator GCaMP6m, whose intensity directly correlates with 
intracellular calcium ion concentrations (1, 13-15). Previous work has shown that calcium 
increases are associated with very early loss of membrane integrity, as occurs in target cells after 
CTLs secrete their lytic granules containing perforin, which leads to the formation of pores in the 
target cell membrane (15-19). Thus, the increase in GCaMP6 intensity in the targets was used as 
a surrogate readout of productive lytic granule secretion by CTLs. To visualize actin in real time, 
CTLs were transfected with LifeAct-mEmerald, a fluorescently labeled actin-binding protein that 
allows visualization of polymerized actin in live cell imaging (20). Similar to previous results (6, 
10), we saw a rapid reduction in cortical actin density at the synapse after CTL contact with 
target cells (Fig. 1A, 0:00 to 1:00 and Movie S1; Fig. S1 and Movie S2). This was followed by 
increased Ca2+ flux in targets (Fig. 1A, 1:20 and Movie S1), consistent with the effects of 
secretion of cytolytic granules by CTLs. Notably, once Ca2+ flux was observed in targets, 
cortical actin density recovered at the synapse in greater than 90% of the CTL:target conjugates, 
(Fig. 1A, 1:20 to 2:20), with a mean time of 1.83r0.96 minutes (meanrSD) following the 
initiation of GCaMP6 fluorescence (Fig. 1B). Thus, cortical actin appears to recover in CTLs 
after the directed secretion of cytolytic granules in cell conjugates.  
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Cortical actin recovery correlates with lytic granule secretion 
To more fully evaluate the relationship between actin dynamics and lytic granule 
secretion, we applied a total internal reflection fluorescence (TIRF)-based imaging approach to T 
cell activation on a planar surface, which permits a rapid high-resolution view of the T cell 
synapse throughout stimulation, suitable for imaging granule fusion at the plasma membrane 
(21). To follow the fate of lytic granules, CTLs were co-transfected with LifeAct-mApple and 
LAMP1-EGFP, a marker for lytic granules (10). Cells were activated on anti-CD3-coated glass, 
allowing us to simultaneously visualize cortical actin density and lytic granule secretion over 
time. Upon engagement by anti-CD3, we observed a rapid reduction in cortical actin density at 
the center of the synapse, giving rise to a ring-like actin structure (Fig. 1C, first panel), as 
previously reported (6, 10). This was followed by the movement of lytic granules into the TIRF 
field (Fig. 1C and Movie S3). At various points after the appearance of granules, we observed 
the rapid diffusion of the LAMP1-EGFP fluorescent signal as the granule fused with the plasma 
membrane; this appeared as an explosion of fluorescence that rapidly diffused and disappeared 
(Fig. 1C, 0:26, and Movie S3). This phenomenon was distinct from lytic granules moving out of 
the TIRF field, which was not associated with diffusion of the EGFP signal in the plasma 
membrane. Notably, TIRF imaging confirmed that after degranulation, cortical actin density 
recovered across the immunological synapse (Fig. 1C, last panel).  
To follow the kinetics of actin and degranulation, we focused on cells that were captured 
before actin had cleared, or early enough after clearance that lytic granules had not yet appeared 
in the TIRF field. Cells included in our analyses exhibited a contact interface that was large 
enough so that granule secretion events were sufficiently spatially separated for accurate 
quantification. Over time, 78% (51/65) of cells meeting this criteria degranulated, as indicated by 
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the diffusion of LAMP1-EGFP in the plasma membrane, with an average of 3.8r2.9 (meanrSD) 
granules fused per cell. Of the 51 cells in which we observed degranulation, 94% (48/51) 
recovered cortical actin across the synapse within the 20-minute window in which they were 
imaged in TIRF. In contrast, of the 14 cells that had not visibly degranulated, only 14% (2/14) 
recovered cortical actin within the same time period.  The mean time to actin recovery following 
fusion of the last granule in TIRF was 1.6r1.0 minutes (meanrSD) (Fig. 1D), which closely 
approximates the time to actin recovery observed in our live-cell imaging (Fig. 1B). This 
recovery of cortical actin density in the center of the synapse contrasts with studies in Jurkat and 
CD4+ cells, which do not secrete lytic granules, and in which actin rings are maintained for >40 
minutes (21, 22). Interestingly, we noted that although granules could still be seen in the TIRF 
field behind the recovered cortical actin meshwork, once actin recovered, fusion was no longer 
observed. Thus, secretion only occurred during the period of actin clearance, actin recovery 
occurred after secretion, and once actin density recovered, secretion was no longer observed.  
 
High resolution visualization of recovered actin at the synapse 
To further evaluate the relationship between actin and lytic granules, we turned to 
structured illumination microscopy (SIM) in conjunction with a TIRF-based imaging system, 
(TIRF-SIM) (23), to visualize the recovered cortical actin network. OT-I CTLs expressing 
LAMP1-GFP were plated on anti-CD3-coated coverslips and fixed after 10 minutes, a time when 
most cells had already secreted lytic granules and recovered a dense cortical actin network across 
the synapse, as visualized by phalloidin staining (Fig. 2A). Notably, 3D reconstruction of SIM 
(3D-SIM) of phalloidin-stained CTLs expressing LAMP1-EGFP revealed that granules were 
localized behind the rich cortical actin meshwork (Fig. S2 and Movie S4). Granule positioning 
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behind the actin barrier was also evident in successive z stacks obtained using a confocal system 
fitted with an Airyscan module that increases resolution (Fig. 2B and Movie S5). These results 
raise the possibility that recovered cortical actin could serve as a physical barrier.  
 
Cortical actin acts as a barrier to prevent secretion 
 The high resolution view of cortical actin at the synapse, in conjunction with the temporal 
correlation between actin recovery and the cessation of secretion, suggested to us that the 
recovered cortical actin could serve as a mechanism for regulating secretion in CTLs. To test this 
hypothesis, OT-I CTLs expressing LifeAct-mApple and LAMP1-EGFP were allowed to interact 
with anti-CD3-coated glass, secrete lytic granules, and recover cortical actin. At this point, cells 
were treated with a carrier control, or Latrunculin A (LatA) to depolymerize actin, and monitored 
using time lapse TIRF microscopy to observe the effects of treatment on lytic granule secretion. 
After treatment with LatA (Fig. 3A, 0:00 and Movie S6), we saw a rapid reduction in the 
intensity of cortical actin (0:15 to 0:45), demonstrating disassembly of the actin network. The 
reduction in cortical actin density was followed by lytic granule movement closer to the plasma 
membrane in the TIRF field, indicated by an increase in LAMP1-EGFP fluorescence intensity 
(Fig. 3A, 0:45 and Movie S6). Moreover, within one minute of the increase in EGFP intensity, 
lytic granule secretion was again observed at the plasma membrane, as indicated by the diffusion 
of EGFP in the TIRF plane (Fig. 3A, 1:30, and Movie S6). Evidence of this diffusion was also 
seen in the accompanying kymographs, which allowed visualization of fluorescence signal under 
a region of interest over time, in the form of a line drawn across the cell. In contrast, cortical 
actin density in carrier-treated cells remained relatively stable across the synapse, as 
demonstrated by the maintenance of the LifeAct-mApple fluorescent signal over time in 
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kymographs. While granules could be seen moving in and out of the TIRF field, the lack of 
LAMP1-EGFP diffusion into the plasma membrane throughout the kymograph and movies 
indicated that granule fusion had not occurred (Fig. 3B and Movie S7). Removal of the cortical 
actin barrier resulted in secretion in 78.9r9.4% of cells compared with secretion in only 
12.5r8.2% of cells treated with a carrier control (Fig. 3C). These results suggest that recovered 
actin does indeed act as a barrier that effectively prevents sustained lytic granule secretion in 
CTLs.  
 
Pharmacological inhibition of PLCJ1 inhibits actin clearance in CTLs  
The regulation of secretion by the actin cytoskeleton raised the question of what factors 
contribute to the control of actin cytoskeletal dynamics at the CTL:target interface. One factor 
known to regulate cortical actin density is phosphatidylinositol 4,5-bisphosphate (PIP2) (7, 24-
26), which can bind and activate a variety of actin regulatory proteins (reviewed in (27)). We 
have previously described a correlation between the reduction in cortical actin density at the 
immunological synapse and decreased levels of PIP2 (10).  
To evaluate whether PIP2 directly affects actin at the synapse, we first tried to alter levels 
of PIP2 pharmacologically in CTLs. One of the key enzymes downstream of the TCR is 
Phospholipase–C gamma 1 (PLCγ1), which cleaves PIP2 into IP3 and DAG, two critical 
intermediates required for T cell activation that trigger Ca2+ flux and cell polarization changes, 
respectively (2, 28, 29). To address whether inhibition of PLCγ1 could modify local levels of its 
substrate, PIP2, at the synapse, we co-transfected CTLs with LifeAct-mApple and a sensor 
expressing the PIP2-binding domain of Tubby fused to EGFP (Tubby-EGFP) (30, 31). We then 
pretreated cells with either U-73122, an inhibitor of PLCγ1 activity, or U-73343, an inactive 
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analog (32), and allowed CTL:target conjugates to form before fixation. While cells treated with 
the inactive analog showed reduced Tubby-EGFP fluorescence (Fig. 4A), indicative of decreased 
PIP2 at the synapse, U-73122-treated cells maintained uniform Tubby-EGFP fluorescence at the 
CTL:target interface (Fig. 4B). Strikingly, treatment with U-73122, but not the U-73343 control, 
also prevented clearance of cortical actin at the synapse (Fig.4A and B). To rule out that the 
effects of PLCγ1 inhibition on cortical actin dynamics were secondary to defective generation of 
the second messengers IP3 and DAG, we allowed PLCγ inhibitor-treated CTLs to interact with 
target cells and then added phorbol 12-myristate 13-acetate (PMA) and ionomycin, which 
pharmacologically rescues DAG- and Ca2+ flux-mediated effects, respectively. Incubation with 
PMA and ionomycin in the presence of U-73122 failed to restore cortical actin clearance in 
CTLs (Fig. 4C), despite increasing expression of IFNγ and TNFα under the same conditions (Fig. 
S3). These results suggest that TCR-triggered PLCγ1 activation both decreases PIP2 levels and 
contributes to the regulation of cortical actin density at the cytolytic synapse.  
 
Acute PIP2 ablation results in rapid disassembly of cortical actin meshwork  
To more directly test whether altering PIP2 levels affects cortical actin density, we 
employed an inducible system that allows for the selective ablation of PIP2 from the membrane 
(33). Rapamycin treatment of cells transfected with components of this system induces 
dimerization of a membrane-tagged FRB-BFP protein with a cytosolic mRFP-FKBP12 fused to 
the catalytic domain of inositol lipid-5-phosphatase E (5-ptase), which converts PI(4,5)P2 into 
PI4P, thereby recruiting the 5-ptase to the plasma membrane and effectively ablating PIP2 there 
(Fig. S4A). This system has been used previously to look at the effects of PIP2 depletion on 
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actin-mediated membrane ruffling (33) and clathrin-coated pit formation (34), but has not been 
used in conjunction with LifeAct to directly examine cortical actin integrity in real time. 
To directly monitor the effects of acute modulation of PIP2 using live cell imaging, we 
co-expressed the fluorescent reporters, Tubby-EGFP or LifeAct-mEmerald, with components of 
the inducible dimerization system. Because we were unable to obtain sufficient expression levels 
of these constructs in primary murine OT-I CTLs, we performed these experiments in Cos7 cells, 
where we could reproducibly co-express all components at adequate levels for visualization 
using TIRF. Addition of Rapamycin led to an immediate increase in the intensity of mRFP in the 
TIRF field, indicating that the 5-ptase was recruited to the plasma membrane (Fig. 5A and Supp. 
S4B). This was associated with a rapid reduction in the Tubby-EGFP signal, consistent with 
lower PIP2 levels (Fig. S4B and Movie S8). Furthermore, in cells co-expressing LifeAct-
mEmerald with the inducible system, we observed a rapid loss of cortical actin density following 
recruitment of the mRFP-tagged 5-ptase to the plasma membrane. (Figure 5A and 5B and Movie 
S9). In contrast, cells transfected with an FRB construct that failed to recruit the 5-ptase to the 
plasma membrane, did not exhibit changes in cortical actin (Figure 5C and 5D and Movie S10). 
Thus, acute manipulation of PIP2 results in rapid changes in cortical actin density at the plasma 
membrane. 
 
PIP2 levels correlate with cortical actin recovery at the synapse  
To evaluate whether there was a similar correlation between actin and PIP2 during the 
recovery of cortical actin density at the synapse, we co-transfected CTLs with LifeAct-mApple 
and Tubby-EGFP (30, 31) and performed TIRF imaging on CTLs as they formed synapses on a 
planar activating surface. At early time points during interaction with anti-CD3-coated surfaces, 
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we observed that the reduction in cortical actin density at the center of the synapse was 
concurrent with a reduction in levels of PIP2, consistent with our previous CTL:target conjugate 
imaging (Fig. 6A and Movie S11). Moreover, as cortical actin recovered at the synapse, we 
observed a concomitant recovery of Tubby-EGFP. Line scans confirmed the colocalization of 
fluorescence intensity for these two markers across the synapse at both early and late time points 
(Fig. 6Ai and ii, and 6B-C). These data suggest that PIP2 levels not only correlate with the 
reduction in cortical actin density during early interactions, but additionally with the recovery of 
cortical actin across the synapse over time.  
Finally, to confirm that PIP2 recovery was not secondary to actin recovery, we treated 
CTLs after actin recovery with Latrunculin A as previously described in Fig. 3. Although 
treatment with Latrunculin A led to the rapid reduction of intensity of cortical actin, we did not 
observe changes in PIP2 levels at the synapse (Fig. 7A and B and Movie S12, carrier controls in 
Fig. S5 and Movie S13). Thus, altering actin did not affect PIP2 levels, while manipulation of 
PIP2 led to dramatic changes in the cortical actin cytoskeleton. Together, these data suggest that 
PIP2 acts upstream of actin to regulate the cortical actin meshwork. 
 
Secretion-deficient Rab27aash/ash CTLs show impaired actin recovery 
 
In both live confocal and TIRF imaging of CTLs, we noted that cortical actin density 
recovered within two minutes following lytic granule secretion. These observations suggested to 
us that granule secretion itself may play a role in actin recovery. To test this hypothesis, we 
evaluated actin recovery in CTLs that were unable to secrete granules due to a mutation affecting 
RAB27a, a critical component of lytic granule docking machinery. Activation of both WT and 
RAB27A-deficient (Rab27aash/ash) cells on anti-CD3-coated glass led to a rapid reduction in 
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cortical actin density, followed shortly by the appearance of lytic granules within the TIRF field 
(Fig. 8A and B, and Movies S14 and S15). As expected, degranulation was not observed in 
Rab27aash/ash CTLs, evidenced by a lack of diffusion of LAMP1-EGFP in TIRF (Fig. 8A), and 
confirmed in flow-based assays of LAMP1 cycling (data not shown). Remarkably, cortical actin 
density also did not recover in most RAB27a-deficient cells (Fig. 8A and Movie S14). 
Kymographic analyses confirmed that the area of reduced actin cortical density persisted 
throughout the duration of the 20 minute movie in the context of secretion-deficient CTLs when 
compared with WT CTLs, where cortical actin density recovered following secretion (Fig. 8A 
and B, right panels).  
To more accurately quantitate actin recovery in the cell population, WT or Rab27aash/ash 
CTLs were allowed to interact with anti-CD3-coated glass, and fixed at either an early (3 
minutes, before granule secretion in WT CTLs) or a later time point (8 minutes, after granule 
secretion is expected to have occurred in most WT CTLs). Phalloidin staining of fixed cells 
revealed that while most WT CTLs had recovered actin across the synapse after eight minutes, 
secretion-deficient Rab27aash/ash CTLs failed to recover actin as well as their WT counterparts 
(Fig. 8C). Similarly, evaluation of Tubby-EGFP in cells revealed that RAB27a-deficient CTLs 
did not fully recover PIP2 across the synapse (Fig. 8D). Although we cannot rule out distinct 
effects of RAB27a, the observation that cortical actin does not recover in these cells suggests that 
lytic granule secretion might be a controlling mechanism that drives cortical actin recovery in 
CTLs. Taken together, our results support the idea that actin reorganization may be a critical step 
in both initiating and limiting CTL secretion. 
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Discussion   
Studies of CTL:target interactions have revealed an exquisite regulation of cortical actin 
density at the immunological synapse, whereby cortical actin density is rapidly reduced 
specifically at interfaces between T cells and targets prior to lytic granule secretion (9, 10). Here, 
we have monitored cortical actin throughout the duration of TCR-triggered responses in the 
context of secretion and demonstrate that granule fusion in CTLs is consistently followed by the 
recovery of cortical actin across the immunological synapse. Our results suggest that recovered 
cortical actin may act as a barrier to limit granule secretion during a discrete CTL:target 
encounter, and furthermore, that recovery itself is triggered upon granule fusion, providing a 
mechanism that facilitates serial killing during an immune response. We also show that both 
clearance and recovery of cortical actin occurs concomitantly with complementary changes in 
PIP2, suggesting that PIP2 plays a role in tuning cortical actin density at the synapse in CTLs.  
 The role of actin in secretion has been studied in many cell types specializing in 
exocytosis, including NK cells (35-37), mast cells (7), pancreatic E cells (38), and adrenal 
chromaffin cells (39, 40). One model, known as the barrier model, suggests that the actin cortex 
acts to physically prevent vesicles from coming in close enough proximity to the plasma 
membrane for fusion to occur (38). This model is supported by evidence that actin prevents 
access of granules and fusion machinery to the plasma membrane in chromaffin cells (41). Our 
observations suggest that recovery of actin after granule fusion in CTLs may limit further access 
of lytic granules to the plasma membrane, thus preventing further secretion. This hypothesis is 
supported by our experiments showing that the removal of this cortical actin barrier using the 
actin depolymerization agent, Latrunculin A, resulted in resumed fusion of lytic granules. Thus, 
as in other cell types, cortical actin may form a barrier that blocks secretion in CTLs.  
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It has been suggested that actin plays an active role in lytic granule secretion, as lytic 
granules of NK cells appear preferentially localized in small areas of actin “hypodensity”, but 
still within a meshwork of actin across the synapse (35, 36).  In contrast, live cell imaging of 
CTL shows granule secretion occurs in an area of actin depletion across the synapse (9); whether 
remaining actin filaments might play a role in secretion remains to be seen. In this paper, we 
provide evidence that cortical actin density at the synapse recovers in CTLs and acts as a barrier 
to block access of granules to the plasma membrane, preventing sustained secretion. Whether 
dense actin networks also act as a barrier in NK cells is not known. It will also be interesting to 
see whether similar mechanisms for cortical actin regulation of secretion also hold true for 
directional versus non-directional secretion of other factors such as cytokines in T cells, which 
rely on similar stimuli but are found in different vesicular compartments.  
 The observation that cortical actin density recovered across the synapse during 
CTL:target interactions led us to explore what regulates actin dynamics in CTLs. Studies in 
macrophages report that the disassembly of actin around newly formed phagosomes correlated 
with the loss of PIP2 (42). Actin cytoskeletal dynamics during phagocytosis in macrophages has 
been compared to immunological synapse formation in CTLs (43, 44) (and reviewed in (45)). 
Indeed, multiple reports suggest that T cells take up surface molecules from the membrane of 
cells with which they interact (6, 46). We therefore hypothesized that like in macrophages, PIP2 
has a role in regulating actin disassembly in CTLs. In agreement, we previously showed that loss 
of cortical actin density at the synapse correlates with a reduction in PIP2 (10). Our study now 
further suggests that during TCR engagement, PIP2 levels at the T cell synapse can be modulated 
by PLCJ1 activity. Although we cannot rule out other effects of the PLCJ1 inhibitor U-73122, 
treatment with PMA and Ionomycin failed to rescue actin clearance, suggesting these 
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observations were independent of DAG or Ca2+-mediated effects. Indeed, PLCJ1 is recruited to 
and activated at TCR-triggered signaling complexes at the plasma membrane (47), making 
PLCJ1-mediated modulation of PIP2 levels an attractive potential mechanism for regulating actin 
dynamics at the synapse. Moreover, our work now reveals that the recovery of actin also 
coincides with the recovery of PIP2. 
We further provide evidence that processes involved in granule secretion itself may 
trigger recovery of cortical actin at the synapse in CTLs. CTLs from ashen mice, which have a 
mutation leading to the loss of RAB27a, are unable to secrete lytic granules and kill target cells 
(48-50). In these CTLs, cortical actin density remained reduced at the immunological synapse 
long after most WT CTLs had degranulated and recovered their cortical actin. Although we 
cannot rule out a direct effect of RAB27a on actin, these results raise the possibility that 
secretion itself may play a role in the recovery of actin at the synapse in CTLs. Interestingly, 
mutations in RAB27A in humans lead to Griscelli syndrome type 2, a primary immunodeficiency 
associated with defective cytolysis and Hemophagocytic Lymphohistiocytosis, where IFNJ from 
hyperactivated CTLs leads to excessive activation of macrophages. Our observations raise the 
possibility that the hyperactivation of CTLs in Griscelli syndrome type 2 may result in part from 
effects of altered actin dynamics.  
While we demonstrate here that secretion-impaired, RAB27a-deficient CTLs do not 
recover actin as well as secretion-competent CTLs, how granule fusion might trigger actin 
recovery at the synapse in CTLs is not clear. Fusion of lytic granules at the immunological 
synapse introduces new integral membrane proteins into the plasma membrane, including 
LAMP1 and LAMP2, which have large, heavily glycosylated ectodomains that could 
conceivably force apart the membranes between CTLs and their targets and thereby permit 
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inhibitory phosphatases such as CD45 access to abbreviate TCR signaling (51). In turn, this 
could allow the re-accumulation of PIP2 through enzymatic activity or diffusion. Alternatively, 
fusion of granules may directly alter enzymes affecting phosphoinositide distribution or 
generation in the plasma membrane and thereby influence cortical actin density.  
 Based on our data, we propose a model in which the cortical actin meshwork acts as a 
barrier to that terminates secretion after CTL killing as it migrates around the body in search of a 
target. Upon CTL encounter with a target, TCR-triggering initiates a signaling cascade that leads 
to the recruitment of PLCJ1 to signaling complexes at the synapse, where it hydrolyzes PIP2 in a 
localized fashion, thereby affecting actin regulatory factors. Polarization of the centrosome to the 
contact interface then delivers lytic granules to the immunological synapse in a region of reduced 
cortical actin density where they can efficiently fuse. Upon granule secretion the recovery of 
cortical actin across the synapse terminates further secretion. Whether this recovered actin then 
alters dynamics with target cells, allowing detachment to enable subsequent attack of new target 
cells remains an intriguing question. We propose that this secretion-induced cortical actin 
recovery offers a mechanism through which CTLs could limit secretion and preserve their 
capacity for serial killing during an immune response. 
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Materials and Methods 
Mice 
OT-I TCR transgenic (52) and C57BL/6 (Jackson Laboratories, Maine, USA) mice were 
maintained in a Specific Pathogen Free facility. Cells from RAB27aash/ash mice were a generous 
gift from J. Hammer (NHLBI, NIH, Bethesda, MD). Cells were obtained from either male or 
female mice between 6-10 weeks of age. Animal husbandry and experiments were performed in 
accordance with protocols approved by the National Human Genome Research Institute Animal 
Use and Care Committee at the National Institutes of Health. 
 
DNA constructs  
DNA constructs used in this paper were generated as follows. Full length GCAMP6m 
(14) was cloned into the pMIG-R1 retroviral vector using BglII and EcoRI restriction sites to 
generate GCAMP6m-MIG-R1. Cloning of TagRFP-MEM-pMIG and Farnesyl-TagBFP2-pMIG 
were described previously (10). LifeAct-mApple, LifeAct-mEmerald, and mTagBFP2-Farnesyl-
5 were obtained from M. Davidson (Florida State University, Tallahassee, FL). LAMP1-EGFP 
[human LAMP1 with C-terminal fluorescent protein tags] was a gift from G. Patterson (NIBIB, 
NIH, Bethesda, MD), and constructed exactly as described for PA-GFP-lgp120 (53). Constructs 
coding for the PH-binding domain of Tubby fused to EGFP (Tubby-EGFP), PM-FRB-mRFP, 
PM-FKBP-mRFP, and mRFP-5-ptase-FKBP12 were generous gifts from T. Balla (NICHD, NIH, 
Bethesda, MD) (31, 33). To produce PM-FRB-tagBFP2 and PM-FKBP-tagBFP2, the gene 
coding for tagBFP2 was removed from mTagBFP2-MAPTau-N10 using the restriction enzymes 
NotI and AgeI and exchanged with the gene coding for the mRFP fluorophore in the two PM-
localized recruiter constructs. 
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Cell culture 
To generate CTLs from OT-I mice, splenocytes were isolated and stimulated with 10nM 
OVA257-264 peptide (AnaSpec, Fremont, CA, USA) in complete RPMI (RPMI 1640 plus 10% 
fetal calf serum (FCS), 2mM L-glutamine, 50U/mL penicillin/streptomycin, and 50μM β-
mercaptoethanol). Following 3 days of stimulation, cells were resuspended in complete RPMI 
plus 10 IU/mL recombinant human IL-2 (rHIL-2), and seeded in fresh media at 0.5x106 cells/mL 
every 48 hours. CTLs were used between 6 and 8 days after primary in vitro stimulation. To 
generate CTLs cells from WT and Rab27aash/ash mice, purified CD8+ T cells were activated using 
plate-bound 1μg/mL anti-CD3ε (clone 2C11) and 2μg/mL anti-CD28 (both from BioXCell, West 
Lebanon, NH, USA) for 48 hours in complete media. Following stimulation, cells were 
resuspended in fresh media + rhIL-2 and cultured for 4 days before use in assays. To generate 
EL4-GCAMP6m, retroviral supernatants from 293T cells transfected with the GCAMP6m-
MIGR1 vector were used to transduce EL4 cells. Fluorescence activated cell sorting (FACS) was 
used to isolate the top 10% brightest expressing cells. COS7 cells and EL4 cell lines stably 
expressing Farnesyl-TagBFP2-pMIG and TagRFP-MEM-pMIG (described previously (10)), or 
GCAMP6m were maintained in DMEM with 10% FCS, 2mM L-glutamine, 50U/mL 
penicillin/streptomycin, and 50μM β-mercaptoethanol.  
 
Live cell imaging 
To prepare cells for live imaging, 5x106 to 1x107 in vitro-activated CTLs were 
transfected with 2.5μg DNA using the Mouse T Cell Nucleofector Kit (Lonza, Basel, 
Switzerland) 4-6 hours prior to imaging.  
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For spinning-disc confocal imaging of CTL-target interactions, specified targets were 
pulsed with 1μM OVA peptide for 1 hour at 37°C and washed once in serum-free DMEM 
(Gibco, Rockville, MD, USA). Targets were plated for 5 minutes in #1.5 glass 4- or 8-well 
imaging chambers (Lab-Tek, Rockville, MD, USA) previously coated with 0.5μg/ml murine 
ICAM-1/FC (R&D Systems, Minneapolis, MN, USA). Approximately 2x106 CTLs were added 
drop wise to chambers containing targets, and serial confocal 1μm z stacks were acquired at 15-
30-second intervals. Imaging began within five minutes of addition of the CTLs to each chamber. 
Images were acquired on either Nikon Ti3 microscope with a Yokogawa spinning-disk scan head 
(#CSU-X1, Yokogawa; Musashino-shi, Tokyo) and a Photometrics EM-CCD camera, or an Axio 
Observer Z1 microscope (Carl Zeiss Inc., Richmond, VA, USA) with a Zeiss Yokogawa 
Spinning Disk system and a Photometrics Evolve EM-CCD camera (Evolve 512, Tucson, AZ, 
USA).   
For live TIRF microscopy of CTLs, #1.5 8-well glass imaging chambers (LabTek, 
Rockville, MD, USA) were cleaned and sonicated in 1M KOH for 15 min, coated with 0.01% 
poly-L-lysine (Sigma) for 15 min, washed with PBS, and then coated with 2.5μg anti-CD3ε 
(clone 2C11, BioXCell) in PBS for 1 hour at 37°C. PBS was replaced with warm RPMI (without 
phenol red) plus 5% FBS. CTLs (transfected as above) were then plated in chambers. Imaging 
began within two minutes of the addition of T cells to the chamber using Nikon Ti-E microscope 
using a 100x, Apo TIRF 1.49 NA oil-immersion objective (Nikon Instruments; Melville, NY, 
USA) with an iXon3 electron multiplying charged coupled device (EM-CCD, DU-897; Andor 
Technology, Belfast, Northern Ireland) or an Axio Observer Z1 microscope (Carl Zeiss Inc., 
Richmond, VA, USA) with TIRF fiber illuminator, oil immersion 100x TIRF objective, and 
using a cMOS camera (PCO Edge, Kelheim, Germany).  For Latrunculin A experiments, 
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imaging began at least 15 minutes after addition of T cells to the imaging chamber. T cells were 
imaged for one to two minutes prior to the addition of Latrunculin A (1μM final concentration, 
Cayman Chemicals, Ann Arbor, MI, USA) or ethanol control. TIRF imaging continued another 
10-15 minutes following treatment.  
For the plasma membrane PIP2 depletion experiments, COS7 cells were transfected with 
expression plasmids coding for PM-FRB-tagBFP2 (or PM-FKBP-tagBFP2) and mRFP-5ptase-
FKBP12 at a 2:1 molar ratio. Depending on the experiment, cells were co-transfected with either 
Tubby-EGFP or Lifeact-mEmerald. Imaging was performed the following day performed in 8-
well imaging chambers (LabTek) that were coated with 1:400 human Fibronectin (Millipore) for 
30 minutes at room temperature. Transfected COS7 cells were trypsinized, washed and plated 
into the LabTek chambers 30 minutes prior to each experiment. The cells were imaged in TIRF 
for 5-10 minutes prior to the addition of a 3X stock of rapamycin (Sigma) to the chamber (final 
concentration: 100nM). The cells were monitored for another 40 minutes following addition of 
the drug to monitor the effects of 5-ptase recruitment to the PM. TIRF imaging was performed 
on a Nikon Ti3 TIRF microscope with a brick-and-block system to maintain a temperature of 
37°C and atmosphere at 5% CO2.  
 
Fixed cell imaging in TIRF 
 For phalloidin experiments, WT or Rab27aash/ash CTLs were plated in #1.5 4- or 8-well 
glass imaging chambers coated with 2.5μg anti-CD3ε, as described above. After 3 (early) or 8 
(late) minutes following addition of CTLs to wells, media in chambers was replaced with 4% 
PFA for 10 minutes at room temperature, then cells were washed with PBS. Cells in chambers 
were then stained for 10 minutes with AlexaFluor 568 phalloidin (ThermoFisher Scientific, 
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Waltham, MA), and washed again with PBS. Samples were imaged using a 100x, Apo TIRF 
1.49 NA oil-immersion objective with an iXon3 electron multiplying charged coupled device 
(EM-CCD, DU-897).  
For LifeAct-mApple plus Tubby-EGFP imaging of fixed cells in TIRF, cells were co-
transfected with LifeAct-mApple and Tubby-EGFP and added to #1.5 4- or 8-well glass imaging 
chambers coated with 2.5μg anti-CD3ε, as described above. After 3 or 8 minutes, cells in 
chambers were fixed with 4% PFA for 10 minutes at room temperature, washed with PBS, and 
imaged on an Axio Observer Z1 microscope with TIRF fiber illuminator, oil immersion 100x 
TIRF objective, and using a cMOS camera (PCO Edge).   
 
Immunofluorescence confocal microscopy 
Peptide-pulsed targets and transfected CTLs pretreated for 10 minutes at 37 C with 
indicated compounds (U-73122 or U-73343, final concentration 1μM, Sigma, St. Louis, MO, 
USA) were added drop wise to #1.5 4-well glass imaging chambers previously coated with 
0.5μg/ml murine ICAM-1/FC and allowed to interact with targets for five minutes. Cells were 
then either fixed in 4% PFA for 10 minutes, or PMA (final concentration, 20ng/mL, Sigma, St. 
Louis, MO, USA) and ionomycin (final concentration, 1μg/mL, Sigma, St. Louis, MO, USA) 
were added for an additional five minutes, then fixed with 4% PFA. Cells in chambers were 
washed with PBS, and washed and left in PBS before imaging on an Axio Observer Z1 
microscope or the Nikon Ti3 spinning disk microscopes described above. 
For Airyscan imaging, confocal images were collected using a Zeiss LSM 880 confocal 
system fitted with an Airyscan module, mounted on an inverted Zeiss Axio Observer Z1 
microscope with an oil immersion Plan-Apochromat 63x/1.40 DIC objective lens (Carl Zeiss 
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Inc., Thornwood, NY, USA).  All images were acquired in Airyscan mode (Super-Resolution) 
using a 32-channel GaAsP-PMT detector. Excitation wavelengths of 488nm (2.2%) and 561nm 
(0.3%) were used for detection of LAMP1-EGFP and AlexaFluor 568 phalloidin; emissions were 
collected in a BP 420-480 + BP 495-620 filter, respectively. Zeiss ZEN 2.3 (black) software 
package was used for collection and post processing of the images. Airyscan processing was 
done using a 6.3 strength, 3D method. 
 
Structured Illumination Microscopy (SIM) 
 WT CTLs previously transfected with LAMP1-EGFP were added to #1.5 8-well glass 
chambers coated with 2.5μg anti-CD3ε, as described. After 10 minutes at 37 C, cells were fixed 
with 4% PFA, and stained with AlexaFluor 568 phalloidin for 10 minutes at room temperature, 
washed and maintained in PBS. 3D-SIM of these cells was performed on a GE DeltaVision 
OMX SR (Applied Precision Ltd.; GE Healthcare) equipped with a 60× 1.42 NA objective 
(Olympus). Raw data from 3-6 micron Z-stacks were reconstructed using Softworx (Applied 
Precision Ltd.; GE Healthcare) and values between 0.001-0.003 for the Wiener filter constant.  
 
Image acquisition and analysis software, and statistics 
 Image acquisition on systems was controlled using Nikon NIS-Elements, Zeiss Zen Blue 
Software, and OMX Master Control Software AcquireSR. Data were analyzed with Imaris 
Scientific Image Processing and Analysis Software (Bitplane Scientific Software, Zurich, 
Switzerland) and ImageJ (NIH, Bethesda, MD, USA) software. All statistical analyses were 
performed using Microsoft Excel or Graph Pad Prism software. P values less than 0.05 were 
considered statistically significant. 
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Figure Legends 
 
Fig. 1. Cortical actin recovery at the CTL synapse follows lytic granule secretion. (A) 
Spinning disk confocal time lapse images of an OT-I CTL expressing LifeAct-mApple 
(pseudocolored in green) in conjugate with an EL4 target cell expressing GCaMP6m pulsed with 
1μM OVA257-26 (highlighted by dotted line). Images showing signal from the LifeAct channel in 
a single slice correspond to the center of the synapse and are shown in gray scale (top row). 
GCaMP6m fluorescence (red) corresponds to an increase in Ca2+ in the target cell. Data are 
representative from N=26 cells from 5 independent experiments. Time in figure is shown in 
minutes:seconds; scale bar = 5Pm. (B) Graph represents time to actin recovery in CTLs 
following initiation of GCaMP6m fluorescence in the targets. (C) TIRF images of an OT-I CTL 
expressing LifeAct-mApple (red) and LAMP1-EGFP (green) degranulating on anti-CD3-coated 
glass surfaces (merge, bottom row). Top row displays signal from the LifeAct channel and 
middle row from the LAMP1-EGFP channel, shown in gray scale. Degranulation event in the 
middle row is highlighted by a yellow arrowhead. Data are representative of N=65 cells from 9 
independent experiments. Time in figure is shown in minutes:seconds; scale bar = 5Pm. (D) 
Graph represents time to actin recovery in CTLs following fusion of the last granule in TIRF 
movies.  
Fig. 2. High-resolution visualization of recovered actin at the synapse. (A) Representative 
TIRF SIM image of recovered cortical actin in a phalloidin-stained OT-I CTL fixed after 10 
minutes following stimulation on anti-CD3-coated glass surfaces. Scale bar = 3Pm. (B) 
Successive 0.4Pm z stack images obtained via Airyscan of an OT-I CTL expressing LAMP1-
EGFP (green) and phalloidin-stained to visualize actin (red), fixed 10 minutes after stimulation 
on anti-CD3-coated glass surfaces. Scale bar = 5Pm. N=14 from three independent experiments.  
 
Fig. 3. Removal of cortical actin permits secretion in CTLs. Time lapse TIRF images 
showing an OT-I CTL expressing LifeAct-mApple (gray scale, top rows), LAMP1-EGFP (gray 
scale, middle rows), and merged channels (bottom rows, LifeAct-mApple: red; LAMP1-EGFP: 
green) that have already secreted and recovered actin in response to anti-CD3-coated glass (-
0:15), then treated at 0:00 with (A) 1PM Latrunculin A (LatA) or with (B) ethanol (EtOH), the 
carrier control. Degranulation event in (A) is highlighted by a yellow arrowhead. Kymographs of 
movies (right panels): fluorescence under a 5 pixel-thick region of interest (dashed white line) is 
displayed over time. Dashed yellow lines indicate time of treatment addition. Scale bar = 5Pm in 
still TIRF images, scale bar = 2 minutes in kymographs. Time shown in minutes:seconds. (C) 
Graph depicts percent of cells that degranulated after treatment with carrier or LatA (mean r SD). 
N=16 for carrier-treated cells; N=19 LatA-treated cells, from 3 independent experiments.  
 
Fig. 4. Pharmacological inhibition of PLCJ inhibits actin clearance in CTLs. Representative 
spinning disk images of OT-I CTLs expressing LifeAct-mApple (red) and Tubby-EGFP (green) 
interacting with 1PM OVA257-26 peptide-pulsed EL4-Farnesyl-TagBFP2 target cells (blue) in the 
presence of (A) 1PM U-73343 inactive analog control (total N=175), (B) 1PM U-73122 PLCJ 
inhibitor (total N=184), or (C) 1PM U-73122 plus PMA and ionomycin (P/i) at 20ng/mL and 
1Pg/mL, respectively (total N=140). LifeAct-mApple and Tubby-EGFP channels are shown in 
gray scale. Scale bar = 5μm. Regions of fluorescence depletion indicated by yellow arrowheads. 
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(D) Graph depicts the percent of cells in conjugates with recovered actin (mean r SD) from more 
than 3 independent experiments. **P<0.01 calculated by Student’s T-test, ns=not significant. 
 
Fig. 5. Ablation of PIP2 at the membrane results in loss of cortical actin density and 
integrity. Representative TIRF images of Cos7 cells expressing (A) tagBFP2-FRB-PM, mRFP-
5-ptase-FKBP12, and LifeAct-mEmerald, or (C) tagBFP2-FKBP12-PM, mRFP-5-ptase-FKBP12, 
and LifeAct-mEmerald, either before (left panels, i, iii, v) or after (right panels ii, iv, vii) 
Rapamycin treatment. Fluorescence signal from mRFP-5-ptase (top grayscale panels i, ii), 
LifeAct-mEmerald (middle grayscale panels iii, iv), and merged channels (bottom panels v, vi) 
are shown. Quantification of fluorescence intensity of mRFP-5-ptase (red line) and LifeAct-
mEmerald (green line) during (B) PIP2 ablation (N=14) or (D) control conditions (N=8) are 
shown. Black arrowheads indicate time of Rapamycin addition. Solid line is the mean of the data 
and shaded area indicates standard error. Dashed yellow lines (vi) highlight the area from which 
the intensity of the cell was measured. Scale bars = 10um. 
 
Fig. 6. PIP2 correlates with cortical actin density at the synapse. (A) Representative TIRF 
images of an OT-I CTL expressing LifeAct-mApple (red) and Tubby-EGFP (green) interacting 
with anti-CD3-coated glass (merge, bottom row). LifeAct (top row) and Tubby-EGFP (middle 
row) are shown in gray scale. Dashed yellow lines in i, ii indicate area from which line scans at 
(B) 0:48 and at (C) 2:32 are derived from, showing LifeAct (red) and Tubby-EGFP (green) 
intensities across the region of interest. N=11 cells from 4 independent experiments. Scale bars = 
5Pm. Time shown in minutes:seconds. 
 
Fig. 7. Removal of recovered cortical actin does not affect PIP2 at the synapse. (A) Time 
lapse TIRF images of an OT-I CTL expressing LifeAct-mApple (gray scale, top rows) and 
Tubby-EGFP (gray scale, middle rows), or merged channels (bottom rows) that have already 
secreted and recovered actin in response to anti-CD3-coated glass surfaces (-0:40), then treated 
at 0:00 with 1uM Latrunculin A. Kymographs of movies (right panels): fluorescence under a 3 
pixel-thick region of interest (dashed white line) is displayed over time. Dashed yellow lines 
indicate time of treatment addition. Scale bar = 5μm; scale bar = 2 minutes in kymographs. Time 
shown in minutes:seconds. (B) Graph depicts percent of cells that with cleared reporter (LifeAct, 
red bars or PIP2, green bars) at the membrane 3 minutes after treatment with carrier or 
Latrunculin A (mean ± SD). N=19 for carrier-treated cells; N=81 LatA-treated cells, from 3 
independent experiments. 
 
Fig. 8. Secretion-deficient Rab27aash/ash CTLs show impaired actin recovery. Representative 
time lapse TIRF images and kymographs of (A) Rab27aash/ash or (B) WT CTLs expressing 
LifeAct-mApple (red) and LAMP1-EGFP (green) interacting with anti-CD3-coated glass. Gray 
scale images for LifeAct (top rows) and LAMP1 (middle rows) are included; bottom rows show 
merged channels. A yellow arrowhead highlights degranulation event in WT panel. Kymographs 
of movies (right panels). Scale bar = 5Pm in TIRF images, scale bar = 2 minutes in kymographs. 
Time shown in minutes:seconds. WT N=6 and Rab27aash/ash N=9 from 3 three independent 
experiments. (C) Graph represents percent of WT (black bars) or Rab27aash/ash (white bars) cells 
with recovered actin at 3 minutes and 8 minutes after interaction with anti-CD3-coated glass 
(mean r SD). For 3 minute time point, WT N=1791 and Rab27aash/ash=1418. For 8 minute time 
point, WT N=3123 and Rab27aash/ash =3054, both from 3 independent experiments. **P<0.01 
  31 
calculated by Student’s T-test, ns=not significant. (D) Graph represents percent of WT (black 
bars) or Rab27a-/- (white bars) cells with recovered PIP2 at 3 minutes and 8 minutes after 
interaction with anti-CD3-coated glass (mean r SD). For 3 minute time point, WT N=282 and 
Rab27a-/-=299. For 8 minute time point, WT N=288 and Rab27a-/- =248. Actin and PIP2 were 
quantitated from 2 different sets of 3 independent experiments. *P<0.05 calculated by Student’s 
T-test, ns=not significant. 
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Supplementary Figure Legends 
Fig. S1. Cortical actin recovers at the synapse during CTL:target interactions. Spinning 
disk confocal time lapse of an OT-I CTL expressing LifeAct-mEmerald (green) interacting with 
an EL4 target cell expressing TagRFP-MEM (red) pulsed with 1μM OVA257-26 (merge, bottom 
row, highlighted by dotted line). Images showing signal from the LifeAct (488) channel in a 
single slice correspond to the center of the synapse and are shown in gray scale (top row). 
Yellow arrowheads highlight area of reduced cortical actin density. Representative of N=11 cells 
from 3 independent experiments. 
 
Fig. S2. 3D SIM of recovered actin and lytic granules at the synapse. (A) Representative 3D 
SIM projection of recovered cortical actin in a phalloidin-stained OT-I CTL fixed after 10 
minutes following stimulation on anti-CD3-coated glass surfaces. (B) 3D SIM image rotated 90 
degrees in the z plane to visualize actin (top panel, grayscale), LAMP1 (middle panel, grayscale), 
or merge (bottom panel) showing LAMP1+ granules on the cytosolic side of recovered cortical 
actin. Granules are highlighted by a yellow dotted line in the LAMP1 panel. Scale bars = 5μm. 
 
Fig. S3. CTL function in U-73122-treated CTLs is rescued by PMA/ionomycin. Intracellular 
cytokine production is inhibited in U-73122-treated CTLs, but is rescued by PMA plus 
ionomycin treatment in the presence of the inhibitor. In vitro activated OT1 CTLs treated with 
either U-73122 or U-73433 control (both 1μM, final concentration) and stimulated for six hours 
with 5μg/mL plate-bound anti-CD3 or left un-stimulated as a control, +/- PMA (20ng/mL, final 
concentration) and ionomycin (1μg/mL, final concentration). Representative of two independent 
experiments.  
 
Fig. S4. 5-phosphatase recruited by Rapamycin inducible dimer system reduces levels of 
PIP2 in plasma membrane. (A) Schematic of inducible dimer system for the manipulation of 
plasma membrane-localized PIP2. A cytosolic 5-phosphatase linked to mRFP is recruited to the 
PM by way of a Rapamycin-dependent heterodimerization of FKBP12 with membrane-bound 
FRB. (B) Representative TIRF images of COS7 cells expressing mRFP-FKBP12-5-ptase (i,ii), 
Tubby-EGFP (iii,iv), and tagBFP2-FRB-PM (not pictured) before treatment with Rapamycin 
(i,iii,v) and after treatment (ii,iv,vi). Merged before and after image shown in (v,vi). Scale bar = 
10μm. 
 
Fig S5. Carrier control experiment for Latrunculin treatment of LifeAct-mApple and 
Tubby-EGFP-expressing CTLs. (A) Time lapse TIRF images of an OT-I CTL expressing 
LifeAct-mApple (gray scale, top rows) and Tubby-EGFP (gray scale, middle rows), or merged 
channels (bottom rows) that have already secreted and recovered actin in response to anti-CD3-
coated glass surfaces (-0:40), then treated at 0:00 with EtOH, the carrier control for Latrunculin 
A. Kymographs of movies (right panels): fluorescence under a 3 pixel-thick region of interest 
(dashed white line) is displayed over time. Dashed yellow lines indicate time of treatment 
addition. Scale bar = 5μm. Time shown in minutes:seconds.  
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Supplementary Movie Legends 
Movie S1. Cortical actin recovers at the synapse following loss of membrane integrity in 
targets. Spinning disk movie showing a single slice through the center of the synapse of an OT-I 
CTL expressing LifeAct-mEmerald (left panel) interacting with a 1μM OVA257-26 peptide-pulsed 
EL4 labeled with GCaMP6m. Merged channel images shown in the right panel. Two-color 
images acquired every 10 seconds. Time shown in minutes:seconds. Scale bar = 10μm. 
 
Movie S2. Cortical actin recovers at the synapse during CTL:target interactions. Spinning 
disk movie showing a single slice through the center of the synapse of an OT-I CTL expressing 
LifeAct-mEmerald (left panel) interacting with a 1μM OVA257-26 peptide-pulsed EL4 expressing 
tagRFP-MEM. Merged channel images shown in the right panel. Two-color images acquired 
every 5 seconds. Time shown in minutes:seconds. Scale bar = 5μm.  
 
Movie S3. Cortical actin recovery in CTLs follows lytic granule secretion. TIRF movie of an 
OT-I CTL expressing LifeAct-mApple (left panel), and LAMP1-EGFP (center panel) interacting 
with glass coated with anti-CD3ε antibodies. Merged channel images shown in the right panel. 
Two-color images acquired every 2.4 seconds. Time shown in minutes:seconds. Scale bar = 5μm. 
 
Movie S4. Recovered cortical actin forms a barrier behind which lytic granules are 
observed. 3D SIM movie of an OT-I CTL expressing LAMP1-EGFP (green) and stained with 
phalloidin to visualize actin (red) rotated in the z plane. Scale bar = 5μm. 
 
Movie S5. Airyscan confocal moving through z stack. Successive 0.2Pm z stack images 
obtained via Airyscan confocal imaging of an OT-I CTL expressing LAMP1-EGFP (green) and 
phalloidin-stained to visualize actin (red), fixed 10 minutes after stimulation on anti-CD3-coated 
glass surfaces. Scale bar = 5Pm. N=14 from three independent experiments. 
 
Movie S6. Removal of cortical actin following Latrunculin A treatment permits secretion in 
CTLs. TIRF movie of an OT-I CTL expressing LifeAct-mApple (left panel) and LAMP1-EGFP 
(center panel) interacting with glass coated with anti-CD3ε antibodies. Merged channel images 
shown in the right panel. Latrunculin A introduced at time 2:00. Two-color images acquired 
every 2.0 seconds. Time shown in minutes:seconds. Scale bar = 5μm.  
 
Movie S7. Carrier control for Latrunculin A treatment has no effect on actin density and 
secretion in CTLs. TIRF movie of a WT CTL expressing LifeAct-mApple (left panel) and 
LAMP1-EGFP (center panel) interacting with glass coated with anti-CD3ε antibodies. Merged 
channel images shown in the right panel. Ethanol (carrier control for Latrunculin A) introduced 
at time 1:30. Two-color images acquired every 1.4 seconds. Time shown in minutes:seconds. 
Scale bar = 5μm.  
 
Movie S8. Rapamycin-induced 5-ptase recruitment to the plasma membrane leads to 
reductions in PIP2. TIRF movie of COS7 cells expressing Tubby-eGFP (left), FKBP12-5-ptase-
mRFP (centre), and tagBFP2-FRB-PM (not pictured). Merged images shown in the right panel. 
Rapamycin is introduced to culture medium at 1:02. Images acquired on a 2.0 second interval, 
scale bar = 10μm.  
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Movie S9. Ablation of PIP2 at the membrane results in loss of cortical actin density and 
integrity. TIRF movie of COS7 cell expressing Lifeact-mEmerald (left), FKBP12-5-ptase-
mRFP (centre), and tagBFP2-FRB-PM (not pictured). Merged images displayed in the right 
panel. Rapamycin is introduced to culture medium at 5:00. Images acquired on a 50 second 
interval, scale bar = 10μm.  
Movie S10. Control for PIP2 ablation; Rapamycin treatment has no effect on actin density. 
TIRF movie of COS7 cell expressing Lifeact-mEmerald (left), FKBP12-5-ptase-mRFP (centre), 
and tagBFP2-FKBP-PM (not pictured). Merged images displayed in the right panel. Rapamycin 
is introduced to culture medium at 6:30. Images acquired on a 15 second interval, scale bar = 
10μm. 
 
Movie S11. PIP2 clearance and recovery correlates with cortical actin density at the 
synapse. TIRF movie of a WT CTL expressing LifeAct-mApple (left panel) and Tubby-EGFP 
(center panel) interacting with glass coated with anti-CD3ε antibodies. Merged channel images 
shown in the right panel. Two-color images acquired every 4 seconds. Time shown in 
minutes:seconds. Scale bar: 5μm.  
 
Movie  S12. Removal of recovered cortical actin does not affect PIP2 at the synapse. TIRF 
movie of an OT-I CTL expressing LifeAct-mApple (left panel) and Tubby-EGFP (center panel) 
interacting with glass coated with anti-CD3ε antibodies. Merged channel images shown in the 
right panel. Latrunculin A introduced at time 0:48. Two-color images acquired every 3 seconds. 
Time shown in minutes:seconds. Scale bar = 5μm.  
 
Movie  S13. Carrier control for Latrunculin A treatment has no effect on actin or PIP2 in 
CTLs.  TIRF movie of an OT-I CTL expressing LifeAct-mApple (left panel) and Tubby-EGFP 
(center panel) interacting with glass coated with anti-CD3ε antibodies. Merged channel images 
shown in the right panel. Ethanol (carrier control for Latrunculin A) introduced at time 1:12. 
Two-color images acquired every 3 seconds. Time shown in minutes:seconds. Scale bar = 5μm.  
 
Movie S14. Secretion-deficient Rab27a-/- CTLs show impaired actin recovery. TIRF movie 
of a Rab27A-deficient CTL expressing LifeAct-mApple (left panel) and LAMP1-EGFP (center 
panel) interacting with glass coated with anti-CD3ε antibodies. Merged channel images shown in 
the right panel. Two-color images acquired every 2.1 seconds. Time shown in minutes:seconds. 
Scale bar = 5μm.  
 
Movie S15. WT control CTLs for Rab27a-/- experiment secrete lytic granules and recover 
actin across the synapse. TIRF movie of a WT, secretion competent CTL expressing LifeAct-
mApple (left panel) and LAMP1-EGFP (center panel) interacting with glass coated with anti-
CD3ε antibodies. Merged channel images shown in the right frame. Two-color images acquired 
every 2.4 seconds. Time shown in minutes:seconds. Scale bar = 5μm.  
 
